FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells
Open Access
- 13 November 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 77 (3) , 560-569
Abstract
The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily and plays an important role in the pathogenesis of cardiovascular diseases via regulating the metabolism and transport of cholesterol. We and others have recently shown that FXR is also expressed in the vasculature, including endothelial cells and smooth muscle cells (SMC). However, the biological significance of FXR activation in SMC is still poorly understood. In this study, we examine the effect of FXR ligands on the angiotensin system in rat aortic SMC (RASMC), as angiotensin II (Ang II) signalling contributes to various types of vascular lesions by promoting cell growth of vascular SMC. Treatment of RASMC with a FXR ligand showed no obvious effect on the expression of angiotensinogen, Ang II type 1 receptor (AT1R) or type 4 receptor (AT4R) but led to a significant increase in the expression of type 2 receptor (AT2R). FXR ligand treatment also resulted in an inhibition of Ang II-mediated extracellular signal-regulated kinase (ERK) activation and growth proliferation. Promoter reporter gene and electrophoretic mobility-shift assays suggest that FXR upregulates AT2R expression at a transcriptional level. Upregulation of AT2R appears to play a role in the FXR-mediated inhibition of ERK activation via upregulation of Rous sarcoma oncogene (Src) homology domain-containing tyrosine phosphatase 1 (SHP-1) because FXR-mediated upregulation of SHP-1 can be blocked by an AT2R antagonist and FXR-mediated ERK inactivation was significantly attenuated via treatment with either an AT2R antagonist or a SHP-1 inhibitor. FXR in SMC may serve as a novel molecular target for modulating Ang II signalling in the vasculature.Keywords
This publication has 50 references indexed in Scilit:
- Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinaseJournal Of Hypertension, 2006
- The AT2 receptor—A matter of love and hatePeptides, 2005
- Cardiovascular and Renal Regulation by the Angiotensin Type 2 ReceptorHypertension, 2005
- Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonistsAmerican Journal of Hypertension, 2005
- β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor StimulationJournal of Biological Chemistry, 2005
- Peroxisome proliferator-activated receptors and cardiovascular remodelingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating ActivityHypertension, 2004
- Vascular Inflammation and the Renin-Angiotensin SystemArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Retinoids Inhibit the Actions of Angiotensin II on Vascular Smooth Muscle CellsCirculation Research, 2001
- The Cardiac Renin-Angiotensin SystemCirculation Research, 1999